HCM — HUTCHMED (China) Cashflow Statement
0.000.00%
Last trade - 00:00
- $3.04bn
- $2.33bn
- $838.00m
- 51
- 25
- 62
- 43
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -104 | -116 | -167 | -360 | 101 |
Depreciation | |||||
Non-Cash Items | -26.4 | -68.6 | -127 | -17.3 | -4.54 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 44.2 | 116 | 82.4 | 100 | 114 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -80.9 | -62.1 | -204 | -269 | 219 |
Capital Expenditures | -8.56 | -19.6 | -16.8 | -36.7 | -32.6 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 128 | -106 | -290 | 333 | -259 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 119 | -125 | -306 | 297 | -291 |
Financing Cash Flow Items | -1.28 | -9.6 | -39.4 | -25.7 | -9.07 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.49 | 296 | 650 | -82.8 | 48.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 35.1 | 114 | 142 | -64.3 | -29.7 |